Managing Tariff Impacts

An Open Letter to Our Customers


Managing Tariff Impacts

As global economic conditions continue to evolve, we remain steadfast in our mission to provide high-quality, affordable, and reliable medicines and medical technologies to the caregivers and patients who depend on us. Recently, fluctuating tariff conditions in the United States have created new challenges across industries, and we want to assure you that we are actively managing this situation.

 

What We're Doing to Manage Tariff Impacts

Commitment to Local-for-Local Manufacturing
Our global manufacturing strategy is built around a local-for-local approach, emphasizing supply chain resilience and responsiveness. We produce 70% of the medicine we sell in the U.S. domestically and source high-value active ingredients locally when possible. We’ve invested nearly $1 billion in U.S. manufacturing and logistics in recent years, a commitment that differentiates us from many others.

Immediate Mitigation Measures
To minimize immediate impacts, we have increased inventories of key materials sourced internationally and diversified our supplier network to ensure continuity of supply. These efforts are designed to reduce the risk of disruption while maintaining product availability.

Introducing Our Pledge to Customers
We recognize that our customers—including hospitals, clinics and blood centers—are also under financial pressure. As we navigate this environment, we are proud to introduce our Pledge to Customers, which reaffirms our commitment to transparency, ethical practices and responsible decision-making.

Potential Impact on Product Pricing
While we are taking every possible measure to mitigate the effects of tariffs, some adjustments to product pricing may be necessary. If price changes become unavoidable, we are committed to communicating these changes openly and transparently.

We appreciate the trust you place in us and are committed to delivering value, reliability and quality. Thank you for your understanding and support.






OUR PLEDGE TO CUSTOMERS IN RESPONDING TO TARIFFS

  1. Supporting U.S. Manufacturing and Doing More in America
    More than 70 percent of our U.S. medicines and 100 percent of our IV pumps and apheresis hardware are manufactured in America and we are expanding in the U.S., supporting local economies, helping ensure supply chain resilience and delivering award-winning service. Learn more at www.moreinamerica.com.
  2. Access, Affordability and Quality
    We prioritize product access, affordability and quality, striving to minimize price increases caused by tariffs while ensuring patients, caregivers and blood collectors have access to safe, reliable and effective medicines and technologies.
  3. Transparency and Open Communication
    We will communicate openly about any necessary adjustments resulting from tariffs, ensuring clarity and trust at every step.
  4. Mitigating Cost Impacts Through Partnerships
    By collaborating closely with our suppliers, we actively seek cost-effective solutions to reduce the financial impact of tariffs and maintain fair pricing for our customers.
  5. Ethical Practices and Long-Term Commitment
    We uphold the highest standards of ethics and compliance and never exploit market conditions to disadvantage our customers or business partners. Our focus is on building long-term sustainable, trusted partnerships that support stability and growth.